Mach-1 Financial Group’s ResMed RMD Stock Holding History

Mach-1 Financial Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$475K	Sell	2,114 -296	-12%	-$73.8K	0.17%	91
2025 Q4	$580K	Buy	+2,410	New	+$616K	0.12%	153
2025 Q3	–	Sell	-4,476	Closed	-$1.15M	–	380
2025 Q2	$1.15M	Sell	4,476 -66	-1%	-$15.7K	0.34%	73
2025 Q1	$1.02M	Buy	+4,542	New	+$1.06M	0.3%	84
2022 Q4	–	Sell	-100	Closed	-$21K	–	384
2022 Q3	$21K	Hold	100	–	–	0.02%	163
2022 Q2	$20K	Buy	+100	New	+$21.3K	0.01%	178

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mach-1 Financial Group's RMD Position: Q1 2026 in Review

Mach-1 Financial Group reduced its ResMed (RMD) stake by 12% in Q1 2026, selling an estimated $73.8K and leaving 2,114 shares worth $475K. The position accounts for 0.17% of the portfolio, ranked #91.

Mach-1 Financial Group first reported a position in RMD in Q2 2022 and has held it in 6 quarters since. The position peaked at $1.15M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Mach-1 Financial Group held 2,114 shares of ResMed worth $475K as of Q1 2026.
Mach-1 Financial Group sold 296 ResMed shares in Q1 2026, an estimated $73.8K.
ResMed made up 0.17% of Mach-1 Financial Group's portfolio in Q1 2026, its #91 holding.
Mach-1 Financial Group first reported a position in ResMed in Q2 2022 and has held it in 6 quarters since.
Mach-1 Financial Group's ResMed position peaked at $1.15M in Q2 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Mach-1 Financial Group's 13F filing for Q1 2026, filed 13 May 2026.